Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1249190.RAEuOJjal7CRsiaTZsJ5Kf4BxNq_O44GTx7lKMeyJ2ML4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1249190.RAEuOJjal7CRsiaTZsJ5Kf4BxNq_O44GTx7lKMeyJ2ML4130_assertion type Assertion NP1249190.RAEuOJjal7CRsiaTZsJ5Kf4BxNq_O44GTx7lKMeyJ2ML4130_head.
- NP1249190.RAEuOJjal7CRsiaTZsJ5Kf4BxNq_O44GTx7lKMeyJ2ML4130_assertion description "[Safety and efficacy of dacomitinib in korean patients with KRAS wild-type advanced non-small-cell lung cancer refractory to chemotherapy and erlotinib or gefitinib: a phase I/II trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249190.RAEuOJjal7CRsiaTZsJ5Kf4BxNq_O44GTx7lKMeyJ2ML4130_provenance.
- NP1249190.RAEuOJjal7CRsiaTZsJ5Kf4BxNq_O44GTx7lKMeyJ2ML4130_assertion evidence source_evidence_literature NP1249190.RAEuOJjal7CRsiaTZsJ5Kf4BxNq_O44GTx7lKMeyJ2ML4130_provenance.
- NP1249190.RAEuOJjal7CRsiaTZsJ5Kf4BxNq_O44GTx7lKMeyJ2ML4130_assertion SIO_000772 25521398 NP1249190.RAEuOJjal7CRsiaTZsJ5Kf4BxNq_O44GTx7lKMeyJ2ML4130_provenance.
- NP1249190.RAEuOJjal7CRsiaTZsJ5Kf4BxNq_O44GTx7lKMeyJ2ML4130_assertion wasDerivedFrom befree-2016 NP1249190.RAEuOJjal7CRsiaTZsJ5Kf4BxNq_O44GTx7lKMeyJ2ML4130_provenance.
- NP1249190.RAEuOJjal7CRsiaTZsJ5Kf4BxNq_O44GTx7lKMeyJ2ML4130_assertion wasGeneratedBy ECO_0000203 NP1249190.RAEuOJjal7CRsiaTZsJ5Kf4BxNq_O44GTx7lKMeyJ2ML4130_provenance.